These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28344483)

  • 21. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study.
    Al-Mutairi A; AlFayyad I; Altannir Y; Al-Tannir M
    Arch Public Health; 2021 Jul; 79(1):130. PubMed ID: 34253257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The perspective of pharmacist on pharmacovigilance and adverse drug reaction reporting in Asir region, Saudi Arabia.
    Alghazwani Y; Alqahtani AM; Alshuraymi MK; Assiri IM; Shuflut AA; Krishnaraju V; Kumarappan C; Ibrahim ARN; Orayj K
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1667-1680. PubMed ID: 36876701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacovigilance in Israel - tools, processes, and actions.
    Schwartzberg E; Berkovitch M; Dil Nahlieli D; Nathan J; Gorelik E
    Isr J Health Policy Res; 2017 Aug; 6(1):29. PubMed ID: 28760141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
    Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
    Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacovigilance in China: Evolution and future challenges.
    Song H; Pei X; Liu Z; Shen C; Sun J; Liu Y; Zhou L; Sun F; Xiao X
    Br J Clin Pharmacol; 2023 Feb; 89(2):510-522. PubMed ID: 35165914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evaluation of adverse drug reactions in Saudi Arabia: A retrospective observational study.
    Alenzi KA; Alanazi NS; Almalki M; Alomrani H; Alatawi FO
    Saudi Pharm J; 2022 Jun; 30(6):735-741. PubMed ID: 35812140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bulgarian Experience with Adverse Drug Reaction Reports from Patients and Consumers - Retrospective Data-base Study.
    Getova VI; Georgiev SR; Stoimenova AH; Petkova-Georgieva ES
    Folia Med (Plovdiv); 2018 Sep; 60(3):447-453. PubMed ID: 30355838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
    Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare professionals' awareness, attitudes and practices towards pharmacovigilance and spontaneous adverse drug reaction reporting in Jazan Province, Saudi Arabia: A survey study.
    Alqahtani SS; Ahmad S; Alam N; Kashan Syed N; Syed MH; Khardali A; Yasmeen A; Alshahrani AM; I Alzarea A; Alanazi AS; Hassan Elnaem M
    Saudi Pharm J; 2023 Jun; 31(6):979-988. PubMed ID: 37234340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of a pharmacovigilance system in Bahrain.
    Abdulrasool Z
    Saudi Pharm J; 2022 Jun; 30(6):825-841. PubMed ID: 35812145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspective of Saudi undergraduate pharmacy students on pharmacovigilance and adverse drug reaction reporting: A National Survey.
    Alkayyal N; Cheema E; Hadi MA
    Curr Pharm Teach Learn; 2017 Sep; 9(5):779-785. PubMed ID: 29233304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance.
    Almandil NB
    Saudi Med J; 2016 Dec; 37(12):1359-1364. PubMed ID: 27874152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacovigilance in pharmaceutical companies: An overview.
    Mammì M; Citraro R; Torcasio G; Cusato G; Palleria C; di Paola ED
    J Pharmacol Pharmacother; 2013 Dec; 4(Suppl 1):S33-7. PubMed ID: 24347978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
    Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
    J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare professionals and pharmacovigilance of pediatric adverse drug reactions: a 5-year analysis of Adverse Events Reporting System Database of the Food and Drug Administration.
    Bigi C; Tuccori M; Bocci G
    Minerva Pediatr (Torino); 2022 Jun; 74(3):272-280. PubMed ID: 28211644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
    Hussain R; Hassali MA; Hashmi F; Akram T
    J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.